Matches in SemOpenAlex for { <https://semopenalex.org/work/W2421335037> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2421335037 endingPage "265" @default.
- W2421335037 startingPage "258" @default.
- W2421335037 abstract "Two proteins that have been correlated with the occurrence of multidrug resistance in acute myeloid leukemia (AML) are P-glycoprotein (Pgp) and the major vault protein (Mvp/LRP). With the purpose of further quantifying the potential contributions of Pgp-mediated drug efflux and Mvp/LRP to drug resistance in AML we have investigated whether the transport function of Pgp and the expression of Mvp/LRP correlated with the accumulation of daunorubicin (DNR) and the in vitro resistance to DNR cytotoxicity (LC50 by MTT assay) in AML cells. In de novo adult AML, the steady-state DNR accumulation (in pmol/106 cells) correlated with Pgp activity or expression, whereas the LC50 for DNR did not correlate with Pgp activity (measured as the modulation of rhodamine 123 or DNR accumulation by the Pgp inhibitor PSC833) or Pgp expression (measured by flow cytometry with the MRK-16 antibody). The contribution of MRP1 expression to a reduced DNR accumulation seems minor compared to Pgp. In addition, the modulation of the DNR LC50 by PSC833 did not correlate with Pgp protein or activity. The steady-state DNR accumulation showed no correlation with the DNR LC50. The Mvp/LRP expression (immunocytochemical staining) did neither correlate with DNR accumulation nor with the DNR LC50. A significant negative correlation was seen between the Mvp/LRP immunocytochemical staining and Pgp activity, indicating that both markers define (partially) different populations. In conclusion, it is shown that Pgp function, but not Mvp/LRP or MRP1 expression correlate with a low steady-state DNR accumulation in de novo AML. The Pgp activity does, however, not predict the DNR sensitivity in AML measured as in vitro DNR LC50 with an MTT-based assay. The reason for that seems to be that a low DNR accumulation may not be the most important factor in determining the LC50. While the clinical usefulness of these drug resistance tests remains to be proven they do not seem to provide as yet a straightforward explanation for the major cause(s) of clinical chemotherapy failure." @default.
- W2421335037 created "2016-06-24" @default.
- W2421335037 creator A5002972322 @default.
- W2421335037 creator A5011171028 @default.
- W2421335037 creator A5018592613 @default.
- W2421335037 creator A5028287318 @default.
- W2421335037 creator A5035138305 @default.
- W2421335037 creator A5046775582 @default.
- W2421335037 creator A5047263059 @default.
- W2421335037 creator A5062204088 @default.
- W2421335037 creator A5073129226 @default.
- W2421335037 creator A5080912335 @default.
- W2421335037 creator A5082443436 @default.
- W2421335037 date "1999-02-01" @default.
- W2421335037 modified "2023-10-11" @default.
- W2421335037 title "Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?" @default.
- W2421335037 doi "https://doi.org/10.1038/sj.leu.2401331" @default.
- W2421335037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10025900" @default.
- W2421335037 hasPublicationYear "1999" @default.
- W2421335037 type Work @default.
- W2421335037 sameAs 2421335037 @default.
- W2421335037 citedByCount "39" @default.
- W2421335037 countsByYear W24213350372017 @default.
- W2421335037 countsByYear W24213350372019 @default.
- W2421335037 countsByYear W24213350372020 @default.
- W2421335037 countsByYear W24213350372021 @default.
- W2421335037 countsByYear W24213350372022 @default.
- W2421335037 countsByYear W24213350372023 @default.
- W2421335037 crossrefType "journal-article" @default.
- W2421335037 hasAuthorship W2421335037A5002972322 @default.
- W2421335037 hasAuthorship W2421335037A5011171028 @default.
- W2421335037 hasAuthorship W2421335037A5018592613 @default.
- W2421335037 hasAuthorship W2421335037A5028287318 @default.
- W2421335037 hasAuthorship W2421335037A5035138305 @default.
- W2421335037 hasAuthorship W2421335037A5046775582 @default.
- W2421335037 hasAuthorship W2421335037A5047263059 @default.
- W2421335037 hasAuthorship W2421335037A5062204088 @default.
- W2421335037 hasAuthorship W2421335037A5073129226 @default.
- W2421335037 hasAuthorship W2421335037A5080912335 @default.
- W2421335037 hasAuthorship W2421335037A5082443436 @default.
- W2421335037 hasBestOaLocation W24213350371 @default.
- W2421335037 hasConcept C114851261 @default.
- W2421335037 hasConcept C133936738 @default.
- W2421335037 hasConcept C153911025 @default.
- W2421335037 hasConcept C200082930 @default.
- W2421335037 hasConcept C202751555 @default.
- W2421335037 hasConcept C203014093 @default.
- W2421335037 hasConcept C2778461978 @default.
- W2421335037 hasConcept C2778589691 @default.
- W2421335037 hasConcept C2778707650 @default.
- W2421335037 hasConcept C2778729363 @default.
- W2421335037 hasConcept C2781021840 @default.
- W2421335037 hasConcept C553184892 @default.
- W2421335037 hasConcept C55493867 @default.
- W2421335037 hasConcept C86803240 @default.
- W2421335037 hasConcept C89423630 @default.
- W2421335037 hasConceptScore W2421335037C114851261 @default.
- W2421335037 hasConceptScore W2421335037C133936738 @default.
- W2421335037 hasConceptScore W2421335037C153911025 @default.
- W2421335037 hasConceptScore W2421335037C200082930 @default.
- W2421335037 hasConceptScore W2421335037C202751555 @default.
- W2421335037 hasConceptScore W2421335037C203014093 @default.
- W2421335037 hasConceptScore W2421335037C2778461978 @default.
- W2421335037 hasConceptScore W2421335037C2778589691 @default.
- W2421335037 hasConceptScore W2421335037C2778707650 @default.
- W2421335037 hasConceptScore W2421335037C2778729363 @default.
- W2421335037 hasConceptScore W2421335037C2781021840 @default.
- W2421335037 hasConceptScore W2421335037C553184892 @default.
- W2421335037 hasConceptScore W2421335037C55493867 @default.
- W2421335037 hasConceptScore W2421335037C86803240 @default.
- W2421335037 hasConceptScore W2421335037C89423630 @default.
- W2421335037 hasIssue "2" @default.
- W2421335037 hasLocation W24213350371 @default.
- W2421335037 hasLocation W24213350372 @default.
- W2421335037 hasOpenAccess W2421335037 @default.
- W2421335037 hasPrimaryLocation W24213350371 @default.
- W2421335037 hasRelatedWork W1507950115 @default.
- W2421335037 hasRelatedWork W2003679416 @default.
- W2421335037 hasRelatedWork W2015158439 @default.
- W2421335037 hasRelatedWork W2018518436 @default.
- W2421335037 hasRelatedWork W2054737607 @default.
- W2421335037 hasRelatedWork W2055830737 @default.
- W2421335037 hasRelatedWork W2155533610 @default.
- W2421335037 hasRelatedWork W2185137591 @default.
- W2421335037 hasRelatedWork W2791544390 @default.
- W2421335037 hasRelatedWork W4235822820 @default.
- W2421335037 hasVolume "13" @default.
- W2421335037 isParatext "false" @default.
- W2421335037 isRetracted "false" @default.
- W2421335037 magId "2421335037" @default.
- W2421335037 workType "article" @default.